News Center
Why the capital market is so fond of Lijuzhu
Release time:
2016-08-22
As everyone knows, the Chinese capital securities market over the past year has been both thrilling and vast; it has staged legends of eagles soaring in the sky and the disillusionment of high-altitude dives; there have been strong alliances as well as fierce competitions, with some celebrating and others lamenting. It truly is a scene of crashing waves and unpredictable tides, making one's heart race and leaving one at a loss. Only the Livzon Group, standing at the forefront amidst such turbulent waves and sifting sands, steers the ship of Livzon, a vessel with A+H dual listings, navigating the vast sea of pharmaceuticals, cutting through the waves and bravely moving forward. Why can Livzon rise to the challenge? If one must say there is a reason...
As everyone knows, the Chinese capital securities market over the past year has been both thrilling and vast; it has staged legends of soaring eagles and the disillusionment of high dives; there have been strong alliances and fierce competitions, with some celebrating while others lament. It truly is a tumultuous sea, with unpredictable waves, making one's heart race and leaving one at a loss.
Only Lizhu Group, amidst such turbulent waves and the sifting of sands, stands at the forefront, steering the ship of Lizhu, which holds A+H listings, navigating the vast sea of pharmaceuticals, cutting through the waves and bravely moving forward.
Why can Lizhu face challenges head-on? If one must speak of a winning secret, it is that Lizhu firmly believes in and practices the creation of value for shareholders and the public as the foundation of a listed company, enhancing innovation as the core competitiveness, and improving the corporate brand image as the root.
Based on this strategic understanding, Lizhu has been actively laying out precision medicine, steadily promoting biopharmaceuticals, persistently strengthening marketing reforms, encouraging employees to grow together with the company and share the fruits of growth, implementing and fulfilling equity incentive measures, and so on. All of this has led to Lizhu's growth consistently exceeding the industry average for several years. The recently released financial report for the first half of this year shows that Lizhu Group achieved a revenue growth of 21.47% in the first half of this year. The operating profit growth reached 22.74%; the net profit growth year-on-year was 20.01%, with a non-deduction growth of 26.53%. This has made Lizhu a bright spot in the Chinese capital securities market, naturally favored by institutional investors and a wide range of shareholders.
Therefore, the "2016 China Cross-Border Investment and M&A Capital Forum and the 10th Listed Company Value Selection Award Ceremony" held in Yangzhou, themed "New Engine New Power," awarded the top 20 of the top 100 listed companies to Lizhu Group; Mr. Yang Liang, the secretary of the board of Lizhu Group, was awarded the title of Excellent Secretary.
Mr. Liu Xibin, the editor-in-chief of New Lizhu, represented the group at the forum and award ceremony. In light of Lizhu's outstanding performance, Mr. Liu was invited to the stage twice as the first recipient of two awards; the value created by Lizhu Group and its secretary for the Chinese capital securities market has earned full respect, and the acquisition of these two awards is well-deserved. Lizhu will continue to create higher value for shareholders, investors, users, and society as a whole in future development and transformation, further benefiting employees and society in its growth.
Previous Page
Related Information